日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

AstraZeneca to build $200m center in China

Updated: 2011-10-12 09:56

By Ma Zhenhuan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

AstraZeneca to build $200m center in China

AstraZeneca PLC workers load blister strips onto a packing line at a factory in Macclesfield, United Kingdom. The UK-based medical company will create 600 jobs by building a new factory in Taizhou, Jiangsu province. [Photo / Bloomberg]

SHANGHAI - AstraZeneca PLC, one of the world's leading pharmaceutical companies, said it would invest $200 million to launch a new manufacturing facility in China to meet growing demand, including in rural areas.

Construction work on the project, in the China Medical City in Taizhou of East China's Jiangsu province, is scheduled for completion by the end of 2013, creating approximately 600 jobs.

This will be London-based AstraZeneca's largest single investment in a manufacturing facility globally. The new plant will produce intravenous and oral solid products, the company said.

"The new facility will significantly enhance our capacity and allow us to meet the growing healthcare demand of the Chinese population, and help us expand into the 900 million (rural) people outside of the big cities and hospitals," Mark Mallon, president of AstraZeneca China, told China Daily in an exclusive interview on Monday.

"It will also allow us to free up some capacity at our existing manufacturing facility in Wuxi, Jiangsu, to bring on more new innovative products that will be launched over the next few years," he added.

The Chinese pharmaceutical market grew from $10 billion in 2004 to $41 billion in 2010, according to market research agency IMS Health Inc, and it is expected to reach $102 billion by 2015.

Mallon said that he believes the Chinese government's focus on healthcare reform and investment in improving healthcare infrastructure and expanding insurance coverage will continue to drive the company's business growth and increase access to quality medicines over the longer term.

AstraZeneca will launch two new products, Faslodex, a treatment for breast cancer, and Onglyza, a new treatment for Type-2 Diabetes, in China this year.

Mallon also mentioned that the company is planning to launch Brilinta, an oral antiplatelet treatment for acute coronary syndrome, next year in China.

With an enhanced manufacturing capacity and the launch of more innovative new medicines, the company is planning to produce more affordable medicines for Chinese patients. It will adopt a multi-channel approach to sell its products to markets beyond big cities and hospitals.

Aside from the medical sales representatives who deal with individual physicians in big cities, the company has developed a team of about 100 customer service representatives who organize educational programs for small clinics and community health centers in China's rural areas.

It will also set up an inbound and outbound call center to reach out to healthcare professionals through phone calls, helping them learn more about AstraZeneca products, he said.

The company, which entered China in 1993, has invested about $500 million in the country, including an innovation center in Zhangjiang, Shanghai.

主站蜘蛛池模板: 国产h视频 | 欧美在线色 | 在线观看黄色国产 | 欧美日韩亚洲国产综合 | 在线资源站 | 毛片毛片毛片毛片毛片 | 中国黄色大片 | 一区二区三区精品在线 | 自拍欧美日韩 | 神马一区二区三区 | 91精品一区二区 | 亚洲欧美另类一区 | 日韩一区二区三区在线 | 亚洲欧美自偷自拍 | 全部孕妇毛片丰满孕妇孕交 | 丁香婷婷激情 | 99re6这里只有精品 | 91在线入口 | 欧美国产日韩在线观看成人 | 成年人网站在线免费观看 | 糖心vlog免费在线观看 | 国产首页 | 国产三级视频在线播放 | 91av视频在线 | 亚洲欧美色图片 | 日韩欧美中文字幕在线播放 | 欧美三区在线观看 | 久久视频在线 | 亚洲在线观看免费 | 亚洲va| 国产综合图片 | 午夜aaa| 欧美顶级黄色大片免费 | 真实的国产乱xxxx在线91 | 久草免费av | 国产三级在线观看视频 | 国产suv精品一区 | 蜜桃精品噜噜噜成人av | 国产探花一区二区 | 久久福利免费视频 | 欧美日本韩国一区 |